Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients
Conclusion
TBRs of SUVmax were not prognostic indicators for advanced HGSC patients.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nuclear Medicine | Ovarian Cancer | Ovaries | Study | Urology & Nephrology